A Review of the External Validity of Clinical Trials with Beta-Blockers in Heart Failure

BACKGROUND: Beta-blockers (BBs) are the mainstay prognostic medication for all stages of chronic heart failure (CHF). There are many classes of BBs, each of which has varying levels of evidence to support its efficacy in CHF. However, most CHF patients have one or more comorbid conditions such as di...

Descripción completa

Detalles Bibliográficos
Autores principales: Iyngkaran, Pupalan, Toukhsati, Samia R., Thomas, Merlin C., Jelinek, Michael V., Hare, David L., Horowitz, John D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063839/
https://www.ncbi.nlm.nih.gov/pubmed/27773994
http://dx.doi.org/10.4137/CMC.S38444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063839/
https://www.ncbi.nlm.nih.gov/pubmed/27773994
http://dx.doi.org/10.4137/CMC.S38444

Ejemplares similares